Could a common cholesterol pill shield heart during liver transplant?

NCT ID NCT07089589

Completed Knowledge-focused Sponsor: Asan Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked back at the records of nearly 7,000 adults who had a liver transplant to see if taking statins beforehand lowered their risk of major heart problems. Researchers checked for events like heart attack, stroke, and heart failure within 30 days after surgery. The goal is to find out if this simple, existing medication could offer extra protection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: statin drugs (e.g., atorvastatin, simvastatin)
What this could lead to: If statins are found to be helpful, this could lead to a simple, low-cost way to lower heart risks before liver transplant.
What could go wrong: This is an observational study, not a controlled trial, so it can only show links, not cause and effect. The results may be influenced by other health factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIVER TRANSPLANTATION MAJOR ADVERSE CARDIOVASCULAR EVENTS

Contacts and locations

Locations

Asan Medical Center

Seoul, 05505, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.